This website uses cookies. For more information please contact us or consult our privacy policy.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
- Home
- News and Insights
- Insights
- FDA Releases Draft Guidance on Responding to Unsolicited Requests for Off Label Information and Seeks Stakeholder Input on Scientific Exchange
FDA Releases Draft Guidance on Responding to Unsolicited Requests for Off-Label Information and Seeks Stakeholder Input on Scientific Exchange
January 9, 2012, Covington E-Alert
January 26, 2018, Covington Alert
This e-alert reviews trends emerging from warning letters and untitled letters concerning therapeutic product advertising and promotion issued in 2017 by the Office of Prescription Drug Promotion (OPDP) of the Center for Drug Evaluation and Research (CDER), the Office of Compliance and Biologics Quality (OCBQ) of the Center for Biologics Evaluation and Research ...
April 30, 2014, Covington E-Alert
August 10, 2012, Covington E-Alert